LV10917A - Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai - Google Patents

Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai

Info

Publication number
LV10917A
LV10917A LV930816A LV930816A LV10917A LV 10917 A LV10917 A LV 10917A LV 930816 A LV930816 A LV 930816A LV 930816 A LV930816 A LV 930816A LV 10917 A LV10917 A LV 10917A
Authority
LV
Latvia
Prior art keywords
bambuterine
preparation
pharmaceutical compositions
lipid content
lowering pharmaceutical
Prior art date
Application number
LV930816A
Other languages
English (en)
Other versions
LV10917B (en
Inventor
Carl-Axel Bauer
Leif-Ake Svensson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LV10917A publication Critical patent/LV10917A/lv
Publication of LV10917B publication Critical patent/LV10917B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LVP-93-816A 1990-03-16 1993-06-30 New use of bambuterol LV10917B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9000948A SE9000948D0 (sv) 1990-03-16 1990-03-16 New use
PCT/SE1991/000195 WO1991013615A1 (en) 1990-03-16 1991-03-14 New use of bambuterol

Publications (2)

Publication Number Publication Date
LV10917A true LV10917A (lv) 1995-12-20
LV10917B LV10917B (en) 1996-04-20

Family

ID=20378886

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-93-816A LV10917B (en) 1990-03-16 1993-06-30 New use of bambuterol

Country Status (28)

Country Link
US (2) US5837727A (lv)
EP (1) EP0521967B1 (lv)
JP (1) JP3081640B2 (lv)
KR (1) KR100194995B1 (lv)
AT (1) ATE138570T1 (lv)
AU (1) AU653149B2 (lv)
CA (1) CA2077762C (lv)
CZ (1) CZ279308B6 (lv)
DE (1) DE69119896T2 (lv)
DK (1) DK0521967T3 (lv)
EG (1) EG19645A (lv)
ES (1) ES2087291T3 (lv)
GR (1) GR3020700T3 (lv)
HK (1) HK52197A (lv)
HU (1) HU211998B (lv)
IE (1) IE80668B1 (lv)
IL (1) IL97509A (lv)
LT (1) LT3734B (lv)
LV (1) LV10917B (lv)
MY (1) MY114218A (lv)
NZ (1) NZ237279A (lv)
PT (1) PT97052B (lv)
RU (1) RU2093153C1 (lv)
SE (1) SE9000948D0 (lv)
SG (1) SG64895A1 (lv)
SK (1) SK278815B6 (lv)
WO (1) WO1991013615A1 (lv)
ZA (1) ZA911452B (lv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use
US6459316B1 (en) * 2000-12-08 2002-10-01 Intel Corporation Flip flop circuit
JP2005518377A (ja) * 2001-12-14 2005-06-23 ノボ　ノルディスク　アクティーゼルスカブ ホルモン感受性リパーゼの活性を低下させるための化合物の使用
US7495028B2 (en) 2002-08-08 2009-02-24 Wen Tan R-bambuterol, its preparation and therapeutic uses
EP2002831A1 (en) * 2002-08-08 2008-12-17 Wen Tan R-Bambuterol, its preparation and therapeutic uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE7689T1 (de) * 1980-07-09 1984-06-15 Aktiebolaget Draco 1-(dihydroxyphenyl)-2-amino-aethanol-derivate, verfahren und mittel zu ihrer herstellung sowie diese derivate enthaltende mittel.
US4472436A (en) * 1982-12-06 1984-09-18 Neo-Bionics, Inc. Increasing HDL-cholesterol levels with phenylethylamine derivatives
EP0244062A3 (en) * 1986-03-03 1990-06-20 Beecham Group Plc Use of aryl ethanol amine derivatives in the treatment of atherosclerosis
SE9000948D0 (sv) * 1990-03-16 1990-03-16 Draco Ab New use

Also Published As

Publication number Publication date
HK52197A (en) 1997-05-02
EP0521967B1 (en) 1996-05-29
PT97052A (pt) 1991-10-31
SK278815B6 (sk) 1998-03-04
MY114218A (en) 2002-09-30
LV10917B (en) 1996-04-20
SE9000948D0 (sv) 1990-03-16
CA2077762A1 (en) 1991-09-17
PT97052B (pt) 1998-07-31
LTIP1735A (en) 1995-07-25
DE69119896T2 (de) 1996-10-10
US6034123A (en) 2000-03-07
KR100194995B1 (ko) 1999-06-15
EG19645A (en) 1995-09-30
RU2093153C1 (ru) 1997-10-20
AU7569191A (en) 1991-10-10
US5837727A (en) 1998-11-17
ZA911452B (en) 1991-11-27
GR3020700T3 (en) 1996-10-31
WO1991013615A1 (en) 1991-09-19
IE910862A1 (en) 1991-09-25
IL97509A (en) 1995-12-31
JP3081640B2 (ja) 2000-08-28
DK0521967T3 (da) 1996-09-09
NZ237279A (en) 1993-08-26
CS9100681A2 (en) 1991-10-15
EP0521967A1 (en) 1993-01-13
CZ279308B6 (cs) 1995-04-12
AU653149B2 (en) 1994-09-22
SG64895A1 (en) 2000-01-25
IE80668B1 (en) 1998-11-18
ES2087291T3 (es) 1996-07-16
HUT61461A (en) 1993-01-28
JPH05504971A (ja) 1993-07-29
IL97509A0 (en) 1992-06-21
DE69119896D1 (de) 1996-07-04
ATE138570T1 (de) 1996-06-15
LT3734B (en) 1996-02-26
HU9202958D0 (en) 1992-12-28
HU211998B (en) 1996-01-29
CA2077762C (en) 2001-06-12

Similar Documents

Publication Publication Date Title
MX9101175A (es) Composicion farmaceutica para administracion nasal
SE8700499D0 (sv) Novel pharmacologically active compounds
UA26303A1 (uk) Фармацевтичhа композиція, яка має імуhосупресорhу та аhтимікробhу активhість
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
NO821645L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater
DE3064910D1 (en) 2-oxo-benzothiazoline, benzoxazoline or indoline derivatives, their preparation, and pharmaceutical compositions comprising such derivatives
FI803935L (fi) Cyklo-oktapeptider och farmaceutiska preparat daerav foerfarande foer deras framstaellning och deras anvaendning
IT8047848A0 (it) Derivati triciclici e loro sali farmacologicamente attivi e composizioni farmaceutiche che li contengono, nonche' procedimento per la loro preparazione
NO157503C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive azepinderivater.
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
NO911065D0 (no) Fremgangsmaate for fremstilling av lipopeptidderivater.
LV10917A (lv) Bambuterina pielietojums lipidu saturu pazeminosu farmaceitisku kompoziciju pagatavosanai
IT1228130B (it) Derivati dell'1,1,2-trifenilpropano e dell'1,1,2-trifenilpropene, procedimento per la loro preparazione e composizioni farmaceutiche contenenti i composti
FI792303A (fi) Farmaceutisk komposition foer rektal administration av kefalosporin
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO163617C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater.
NO164773C (no) Analogifremgangsmaate for fremstilling av forbindelser medfarmasoeytisk virkning.
IT8067851A0 (it) Derivati di cefalosporina sommini strabili per via orale e procedimento per la loro preparazione
JO1692B1 (en) Use of a pharmaceutically acceptable salt
IT8321358A0 (it) Derivati ad attivita' terapeutica della s-carbossimetilcisteina, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
IL78801A (en) N2-naphthalene-sulfonyl-l-argininamides,the pharmaceutically acceptable salts thereof,their preparation and pharmaceutical compositions containing them
IT1133963B (it) Derivati piridossinici ad attivita' terapeutica,procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8819541A0 (it) Composizione farmaceutica per somministrazione nasale.
IL94968A0 (en) Derivatives of taxol,pharmaceutical compositions thereof and methods for the preparation thereof
MX9203359A (es) Nuevas composiciones farmaceuticas de insulina.